메뉴 건너뛰기




Volumn 113, Issue 21, 2009, Pages 5035-5036

miRs: Fine-tuning prognosis in CLL

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD23 ANTIGEN; DNA; IMMUNOGLOBULIN HEAVY CHAIN; MICRORNA; MIRN223 MICRORNA, HUMAN; MIRN29C MICRORNA, HUMAN;

EID: 67149099803     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-02-205419     Document Type: Note
Times cited : (6)

References (8)
  • 5
    • 65549110908 scopus 로고    scopus 로고
    • MiR-34a as part of the chemotherapy resistance network in chronic lymphocytic leukemia
    • Zenz T, Mohr J, Eldering E, et al. MiR-34a as part of the chemotherapy resistance network in chronic lymphocytic leukemia. Blood. 2009;113:3801-3808.
    • (2009) Blood , vol.113 , pp. 3801-3808
    • Zenz, T.1    Mohr, J.2    Eldering, E.3
  • 8
    • 67149147424 scopus 로고    scopus 로고
    • MicroRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification
    • Stamatopoulos B, Meuleman N, Haibe-Kains B, et al. microRNA-29c and microRNA-223 down-regulation has in vivo significance in chronic lymphocytic leukemia and improves disease risk stratification. Blood. 2009; 113:5237-5245.
    • (2009) Blood , vol.113 , pp. 5237-5245
    • Stamatopoulos, B.1    Meuleman, N.2    Haibe-Kains, B.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.